vimarsana.com

Latest Breaking News On - Mantle cell lymphoma - Page 5 : vimarsana.com

Bristol-Myers Squibb Company (NYSE:BMY) Q4 2023 Earnings Call Transcript

Bristol-Myers Squibb Company (NYSE:BMY) Q4 2023 Earnings Call Transcript February 2, 2024 Bristol-Myers Squibb Company isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Bristol-Myers Squibb Fourth Quarter 2023 Earnings Conference Call. All participants will be in listen-only […]

Chronic lymphocytic leukemiaMantle cell lymphomaMassive voteApproval from wall street analystsBristol myers squibb companyFourth quarterDavid elkinsJim powerForward looking statementChris boerner

Dr Danilov on Using MRD Status to Predict Outcomes in Hematologic Malignancies

Alexey Danilov, MD, PhD, discusses the use of minimal residual disease to predict outcomes in patients with follicular lymphoma.

Alexey danilovToni stephenson lymphoma centerDepartment of hematology hematopoietic cell transplantationDivision of leukemiaHematopoietic cell transplantationOnclive tvHematologic oncologyMantle cell lymphoma

Covid in Scotland: Families remember loved ones lost to coronavirus

We share the stories of some of the 12,000 people who have died with coronavirus in Scotland.

United kingdomNorth lanarkshireHome farmKwazulu natalSouth africaWest dunbartonshireNorth ayrshireEast dunbartonshireDumfries and gallowayNew south walesUnited kingdom generalArgyll and buteEast renfrewshireWestern australiaFrance generalBlack bull

Current Treatment Options in First-Line MCL

Experts on mantle cell lymphoma discuss first-line treatment options available for patients.

Recent updatesFollicular lymphomaMantle cell lymphomaTreatment optionsBtk inhibitorsIndolent biologyIntensive therapyFrontline therapyConsolidation therapyAutologous stem cell transplantMcl treatmentMantle cell lymphoma treatment

Unmet Needs in Treating Relapsed/Refractory FL

Laurie Sehn, MD, and Bijal Shah, MD, discuss remaining unmet needs for patients with relapsed/refractory FL.

Bijal shahLaurie sehnRecent updatesFollicular lymphomaMantle cell lymphomaPod 24Tumor microenvironmentUnmet needsSequencing therapyGlobal biologyCirculating tumor dna

vimarsana © 2020. All Rights Reserved.